Gabapentin Capsule
Product Images NDC 50090-7675

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph comparing mean pain score over 8 weeks for placebo versus gabapentin 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period; the y-axis shows mean pain score from 0 to 10. Gabapentin shows a consistent decrease in pain score over time, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting mean pain scores over 7 weeks during a 3-week dose titration period followed by a 4-week fixed dose period. It compares placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups. Pain scores decrease over time with Gabapentin treatments showing lower pain scores than placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) at various doses across two studies. Study 1 shows 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is noted with asterisks, indicating p-values less than 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration of a formula calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a gender correction factor. The formula is relevant to pharmacokinetics or dosing calculations but does not specify any drug-related details in the image.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring attached to an amino methyl group and a carboxymethyl group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing percentage difference on the y-axis versus daily dose in milligrams (600, 900, 1200, 1800 mg) on the x-axis. It compares data points from three studies labeled as Study a, Study b, and Study c, each represented with different symbols. The chart depicts the relationship between daily gabapentin dose and observed difference percentage across the studies.*

FDA Label Image

Label Image (Lbl500907675)

Gabapentin 300 mg oral capsules label from A-S Medication Solutions. The label states each capsule contains 300 mg of gabapentin USP. Packaging includes 90 capsules with storage instructions to store at 68 to 77 degrees Fahrenheit. The label shows the NDC 50090-7675 and additional packaging identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.